These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 4673141

  • 1. Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells.
    Nelson JA, Parks RE.
    Cancer Res; 1972 Oct; 32(10):2034-41. PubMed ID: 4673141
    [No Abstract] [Full Text] [Related]

  • 2. Synergistic effect of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside on the levels of adenine nucleotides of Sarcoma 180 cells.
    Scholar EM, Brown PR, Parks RE.
    Cancer Res; 1972 Feb; 32(2):259-69. PubMed ID: 5058187
    [No Abstract] [Full Text] [Related]

  • 3. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine.
    Tidd DM, Paterson AR.
    Cancer Res; 1974 Apr; 34(4):738-46. PubMed ID: 4856046
    [No Abstract] [Full Text] [Related]

  • 4. Feedback inhibition of purine biosynthesis in adenocarcinoma 755 and sarcoma 180 cells in culture.
    Dixon GJ, Dulmadge EA, Brockman RW, Shaddix SC.
    J Natl Cancer Inst; 1970 Oct; 45(4):681-5. PubMed ID: 5535124
    [No Abstract] [Full Text] [Related]

  • 5. Scheduling of arabinosylcytosine and 6-thioguanine therapy.
    LePage GA, White SC.
    Cancer Res; 1973 May; 33(5):946-9. PubMed ID: 4703126
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside.
    Paterson AR, Wang MC.
    Cancer Res; 1970 Sep; 30(9):2379-87. PubMed ID: 4319905
    [No Abstract] [Full Text] [Related]

  • 8. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine.
    Nelson JA, Carpenter JW, Rose LM, Adamson DJ.
    Cancer Res; 1975 Oct; 35(10):2872-8. PubMed ID: 1157053
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conversion of 6-thioguanine to the nucleoside level by purine nucleoside phosphorylase of sarcoma 180 and sarcoma 180/TG ascites cells.
    Lee SH, Sartorelli AC.
    Cancer Res; 1981 Mar; 41(3):1086-90. PubMed ID: 7459851
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of L-fucose incorporation into glycoprotein of Sarcoma 180 ascites cells by 6-thioguanine.
    Lazo JS, Hwang KM, Sartorelli AC.
    Cancer Res; 1977 Dec; 37(12):4250-5. PubMed ID: 922719
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antitumor activity of N6-phenyladenosine, and inhibitor of adenosine utilization, in combination with related purine analogs.
    Grindey GB, Divekar AY, Hakala MT.
    Cancer Res; 1973 Oct; 33(10):2459-63. PubMed ID: 4741936
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.